Kevin C. Ma

Oct 24, 2024 | cdc.gov | Kevin C. Ma

Weekly / October 24, 2024 / 73(42);938–945 Kevin C. Ma, PhD1,*; Juan Castro, PhD1,*; Anastasia S. Lambrou, PhD1; Erica Billig Rose, PhD1; Peter W. Cook, PhD1; Dhwani Batra, MS, MBA2; Caelin Cubenas, PhD1; Laura J. Hughes, PhD1; Duncan R. MacCannell, PhD2; Paritra Mandal, PhD1,3; Neha Mittal, PhD1; Mili Sheth, PhD4; Casey Smith, MS1; Amber Winn, MPH1; Aron J.

Jun 5, 2024 | medrxiv.org | Kevin C. Ma |Diya Surie |Adam S. Lauring |Emily Martin

AbstractBackground: Assessing COVID-19 vaccine effectiveness (VE) and severity of SARS-CoV-2 variants can inform public health risk assessments and decisions about vaccine composition. BA.2.86 and its descendants, including JN.1 (referred to collectively as "JN lineages"), emerged in late 2023 and exhibited substantial genomic divergence from co-circulating XBB lineages.

Jun 22, 2023 | cdc.gov | Kevin C. Ma

Weekly / June 23, 2023 / 72(25);683–689 Kevin C. Ma, PhD1,2; Vajeera Dorabawila, PhD3; Tomás M. León, PhD4; Hannah Henry, MPH4; Amelia G. Johnson, DrPH1; Eli Rosenberg, PhD3; Joshua A. Mansfield, MSPH5; Claire M. Midgley, PhD1; Ian D. Plumb, MBBS1; Julia Aiken, MPH6; Quratul Ain Khanani, MPH7; Steven Auche, MPH8; Nagla S. Bayoumi, DrPH9; Sarah A.

Jun 15, 2023 | cdc.gov | Kevin C. Ma

Weekly / June 16, 2023 / 72(24);651–656 Kevin C. Ma, PhD1,2,*; Philip Shirk, PhD1,*; Anastasia S. Lambrou, PhD1,2; Norman Hassell, MS1; Xiao-yu Zheng, PhD1; Amanda B. Payne, PhD1; Akilah R. Ali, MPH1; Dhwani Batra, MS, MBA3; Jason Caravas, PhD3; Reina Chau, MS1,4; Peter W. Cook, PhD1; Dakota Howard1,4; Nicholas A. Kovacs, PhD1; Kristine A. Lacek, MS1; Justin S.